Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis Clinical Trial
Official title:
Drug Use Surveillance of Takecab Tablets for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"
The purpose of this survey is to evaluate the safety and effectiveness of vonoprazan tablets in patients with gastric ulcer, duodenal ulcer, and reflux esophagitis in the routine clinical setting.
The drug being tested in this survey is called vonoprazan. Vonoprazan is being tested to
treat patients who have gastric ulcer, duodenal ulcer, and reflux esophagitis.
This survey will look at the safety and effectiveness of vonoprazan in patients with gastric
ulcer, duodenal ulcer, and reflux esophagitis in the routine clinical setting. The survey
will enroll approximately 3000 participants.
- Vonoprazan 20 mg
This multi-center survey will be conducted in Japan.
;